G Protein News and Research

RSS

Study led by TSRI scientists likely to influence future designs for HIV vaccines, antibody-based therapies

A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus—thanks to the diversity of targets the site presents to the human immune system.

16 May 2014

Research professor of Emory receives 2014 MetLife Foundation Awards for Medical Research

Lary C. Walker, PhD, research professor of neuropharmacology and neurologic diseases and associate professor of neurology, Yerkes National Primate Research Center, Emory University, is a recipient of the 2014 MetLife Foundation Awards for Medical Research. The winners were recognized at a scientific briefing and awards ceremony today in New York.

16 May 2014

St. Jude analysis reveals how protein p53 triggers cancer cells to commit suicide

St. Jude Children's Research Hospital scientists have mapped the structural details of how p53 attaches to its regulatory protein, called BCL-xL, in the cell.

16 May 2014

MetLife announces recipients of 2014 MetLife Foundation Awards for Medical Research

MetLife Foundation today announced the recipients of the 2014 MetLife Foundation Awards for Medical Research.

16 May 2014

Researchers test genomic sequencing for women with triple negative breast cancer

Indiana University cancer researchers are testing whether therapy incorporating advanced genomic technology will provide better outcomes than current treatments for those with an aggressive form of breast cancer.

15 May 2014

Shark antibodies reveal evolutionary principles of immunoglobulins

Custom-tailored antibodies are regarded as promising weapons against a multitude of serious illnesses. Since they can accurately recognize specific structures on the surface of viruses, bacteria or cancer cells, they are already being deployed successfully in cancer diagnostics and therapy, as well as against numerous other diseases. The stability of the sensitive antibodies is a decisive factor in every step, from production and storage to therapeutic application.

15 May 2014

New tech could take light-based cancer treatment deep inside the body

Photodynamic therapy (PDT) is an effective treatment for easily accessible tumors such as oral and skin cancer.

15 May 2014

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

Eleven Biotherapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today reported financial results and operational highlights for the quarter ended March 31, 2014.

15 May 2014

Researchers identify certain neurons responsible for behavioral decisions in rats

A new paper published by OIST's Neurobiology Research Unit identifies some of the neurons responsible for behavioral decisions in rats. Using a technique that employs light to control nerve cell activity, researchers in Professor Jeff Wickens' Unit inactivated a region of the brain and showed that it caused the rats to behave more flexibly while trying to get a reward.

15 May 2014

Kamada to present Phase 2/3 clinical trial results of AAT to treat alpha-1 antitrypsin deficiency

Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, will announce results from its Phase 2/3 clinical trial of its proprietary inhaled alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) in Europe and Canada on Friday, May 16, 2014, at approximately 7:30 a.m. Eastern time.

15 May 2014

Novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis

A novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis (PVNS), a rare neoplastic joint disorder, according to new phase I data from Memorial Sloan Kettering Cancer Center and other institutions highlighted to media today in advance of the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), which will take place from May 30 to June 3 in Chicago.

15 May 2014

Suppressing hyperactivity of calcium channels alleviates familial Alzheimer's disease

In 2008, researchers at the Perelman School of Medicine at the University of Pennsylvania showed that mutations in two proteins associated with familial Alzheimer's disease (FAD) disrupt the flow of calcium ions within neurons.

15 May 2014

Scientists find new way to predict response to platinum-based chemotherapy in women with triple-negative breast cancer

Researchers from University Hospitals (UH) Case Medical Center's Seidman Cancer Center will present findings from a study that found the presence of tumor-infiltrating lymphocytes, a type of white blood cell, ahead of treatment may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer.

15 May 2014

Scripps Research Institute scientists show AIDS vaccine could work against changeable site on HIV

A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus-thanks to the diversity of targets the site presents to the human immune system.

15 May 2014

SapC-DOPS technology: New way to image glioblastoma multiforme tumors

Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.

15 May 2014

Scientist wins 2014 Maurice Hilleman/Merck Award for developing vaccine against meningococcal disease

Dan Granoff, MD, of UCSF Benioff Children's Hospital Oakland's research arm CHORI, has been named the 2014 Maurice Hilleman/Merck Award Laureate by the American Society for Microbiology (ASM).

15 May 2014

Anti-depressants could slow onset of Alzheimer's disease

A University of Pennsylvania researcher has discovered that the common selective serotonin reuptake inhibitor (SSRI) citalopram arrested the growth of amyloid beta, a peptide in the brain that clusters in plaques that are thought to trigger the development of Alzheimer's disease (AD).

15 May 2014

G Protein News and Research

Study led by TSRI scientists likely to influence future designs for HIV vaccines, antibody-based therapies

Research professor of Emory receives 2014 MetLife Foundation Awards for Medical Research

St. Jude analysis reveals how protein p53 triggers cancer cells to commit suicide

MetLife announces recipients of 2014 MetLife Foundation Awards for Medical Research

Researchers test genomic sequencing for women with triple negative breast cancer

Shark antibodies reveal evolutionary principles of immunoglobulins

New tech could take light-based cancer treatment deep inside the body

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

Researchers identify certain neurons responsible for behavioral decisions in rats

Kamada to present Phase 2/3 clinical trial results of AAT to treat alpha-1 antitrypsin deficiency

Novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis

Suppressing hyperactivity of calcium channels alleviates familial Alzheimer's disease

Scientists find new way to predict response to platinum-based chemotherapy in women with triple-negative breast cancer

Scripps Research Institute scientists show AIDS vaccine could work against changeable site on HIV

SapC-DOPS technology: New way to image glioblastoma multiforme tumors

Scientist wins 2014 Maurice Hilleman/Merck Award for developing vaccine against meningococcal disease

Anti-depressants could slow onset of Alzheimer's disease

Zinc supplements reduce diarrhoea and infections in malnourished children

New technology has potential to make production of biotech medicines simpler

Antidepressant stops growth of plaques in mouse model of Alzheimer's disease

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News